RxDoctor Payments Data

Thu Thuy Thi Vu

Acute Care · Gastonia, NCNPI 1104490630

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,172, 2.4 times the $499 reported in 2021.

$2,312in general payments, 2019–2025

Across 45 payments — averaging $51.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cvrx, Inc.$484
  • Medtronic$428
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$363
  • Abbott$339
  • Boehringer Ingelheim$220
  • E.r. Squibb & Sons, L.L.C.$132
  • plus $346 from 5 others

What the payments were for

  • Food & beverage$2,312100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,312 in reported general payments places this provider in the 85th percentile of 312 acute care providers in North Carolina.

See all acute care providers in North Carolina

Medicare billing

Part B allowed, 2024
$33,228
Medicare patients
257
Services billed
421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$42,423
EntrestoSacubitril/Valsartan40$34,023
JardianceEmpagliflozin50$32,555
BrilintaTicagrelor15$7,297
Metoprolol Succinate186$2,051
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$710
Spironolactone116$625
Eplerenone22$557
ClopidogrelClopidogrel Bisulfate34$499
Furosemide138$437
Losartan Potassium99$414
Carvedilol69$324
Isosorbide Mononitrate ErIsosorbide Mononitrate50$319
Torsemide20$279
Amlodipine Besylate53$237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$220$32,55550 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 312 acute care providers in North Carolina.

Other acute care in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →